BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 30685743)

  • 1. Functional and endocrine-metabolic oligomenorrhea: proposal of a new diagnostic assessment tool for differential diagnosis in adolescence.
    Baggio S; Di Paola R; Zaffagnini S; Fino S; Raffaelli R; Franchi M
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):135-142. PubMed ID: 30685743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea. The emerging role of polycystic ovary syndrome.
    Nezi M; Christopoulos P; Paltoglou G; Gryparis A; Bakoulas V; Deligeoroglou E; Creatsas G; Mastorakos G
    J Pediatr Endocrinol Metab; 2016 Jun; 29(6):693-702. PubMed ID: 27089404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rational hormonal diagnosis of secondary amenorrhea].
    Moltz L; Trapp M; Bispink G; Leidenberger F
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):228-39. PubMed ID: 2954877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S; van der Spuy ZM
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrinologic features of oligomenorrheic adolescent girls.
    Siegberg R; Nilsson CG; Stenman UH; Widholm O
    Fertil Steril; 1986 Nov; 46(5):852-7. PubMed ID: 3096784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study.
    Taponen S; Martikainen H; Järvelin MR; Laitinen J; Pouta A; Hartikainen AL; Sovio U; McCarthy MI; Franks S; Ruokonen A
    J Clin Endocrinol Metab; 2003 Jan; 88(1):141-7. PubMed ID: 12519843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
    J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.
    Nadaraja RND; Sthaneshwar P; Razali N
    Malays J Pathol; 2018 Apr; 40(1):33-39. PubMed ID: 29704382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction.
    Di Stasi V; Maseroli E; Rastrelli G; Scavello I; Cipriani S; Todisco T; Marchiani S; Sorbi F; Fambrini M; Petraglia F; Maggi M; Vignozzi L
    Front Endocrinol (Lausanne); 2021; 12():641446. PubMed ID: 33854482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rational hormonal diagnosis of oligomenorrhea].
    Weise HC; Moltz L; Bispink G; Leidenberger F
    Geburtshilfe Frauenheilkd; 1989 Aug; 49(8):694-700. PubMed ID: 2529165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated testosterone and hypergonadotropism in active adolescents of normal weight with oligomenorrhea.
    Singer K; Rosenthal A; Kasa-Vubu JZ
    J Pediatr Adolesc Gynecol; 2009 Oct; 22(5):323-7. PubMed ID: 19733321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The androgenic profile of women with non-insulin-dependent diabetes mellitus.
    Tok EC; Ertunc D; Evruke C; Dilek S
    J Reprod Med; 2004 Sep; 49(9):746-52. PubMed ID: 15493567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T; Krzysiek J; Janczak-Saif A; Sztefko K; Krzyczkowska-Sendrakowska M
    Endokrynol Pol; 2005; 56(6):883-90. PubMed ID: 16821206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sex hormone concentrations in adolescent secondary amenorrhoea.
    Siegberg R
    Ann Chir Gynaecol; 1987; 76(3):176-80. PubMed ID: 3674729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS.
    Sikka P; Gainder S; Dhaliwal LK; Bagga R; Sialy R; Sahdev S
    Int J Fertil Womens Med; 2007; 52(1):41-7. PubMed ID: 17987887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
    Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective follow-up of menstrual disorders in adolescence and prognostic factors.
    Wiksten-Almströmer M; Hirschberg AL; Hagenfeldt K
    Acta Obstet Gynecol Scand; 2008; 87(11):1162-8. PubMed ID: 18956264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifollicular ovaries in female adolescents with cystic fibrosis.
    Galli-Tsinopoulou A; Moudiou T; Mamopoulos A; Karamouzis M; Nousia-Arvanitakis S
    Fertil Steril; 2006 May; 85(5):1484-7. PubMed ID: 16600228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.